Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Mallinckrodt
Johnson and Johnson
Express Scripts
Medtronic

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Vaborbactam

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Vaborbactam: Patents, clinical trial progress, indications

Vaborbactam is an investigational drug.

There have been 5 clinical trials for Vaborbactam. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2014.

The most common disease conditions in clinical trials are Infection, Pyelonephritis, and Pneumonia, Bacterial. The leading clinical trial sponsors are Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company), Department of Health and Human Services, and Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.).

There are three US patents protecting this investigational drug and twenty-eight international patents.

Recent Clinical Trials for Vaborbactam
TitleSponsorPhase
A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial PneumoniaMelinta Therapeutics, Inc.Phase 3
Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy VolunteersBiomedical Advanced Research and Development AuthorityPhase 1
Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy VolunteersRempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)Phase 1

See all Vaborbactam clinical trials

Clinical Trial Summary for Vaborbactam

Top disease conditions for Vaborbactam
Top clinical trial sponsors for Vaborbactam

See all Vaborbactam clinical trials

US Patents for Vaborbactam

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Vaborbactam   Start Trial Cyclic boronic acid ester derivatives and therapeutic uses thereof Rempex Pharmaceuticals, Inc. (San Diego, CA)   Start Trial
Vaborbactam   Start Trial Cyclic boronic acid ester derivatives and therapeutic uses thereof Rempex Pharmaceuticals, Inc. (San Diego, CA)   Start Trial
Vaborbactam   Start Trial Cyclic boronic acid ester derivatives and therapeutic uses thereof Rempex Pharmaceuticals, Inc. (San Diego, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Vaborbactam

Drugname Country Document Number Estimated Expiration Related US Patent
Vaborbactam Australia 2011289615 2030-08-10   Start Trial
Vaborbactam Brazil 112013003045 2030-08-10   Start Trial
Vaborbactam Canada 2807546 2030-08-10   Start Trial
Vaborbactam Chile 2013000399 2030-08-10   Start Trial
Vaborbactam China 103180328 2030-08-10   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Express Scripts
Moodys
Mallinckrodt
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.